Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.

Our products are bovine polyclonal antibodies, isolated from the early milk of immunized cows. Nature has designed these antibodies to be both stable to gastric digestion and safe for oral consumption.